Hepatotoxins Stocks List

Recent Signals

Date Stock Signal Type
2021-04-16 ATXI Lower Bollinger Band Walk Weakness
2021-04-16 ATXI Calm After Storm Range Contraction
2021-04-16 ATXI Hammer Candlestick Bullish
2021-04-16 ATXI Lizard Bullish Bullish Day Trade Setup
2021-04-16 CPIX NR7 Range Contraction
2021-04-16 CPIX Narrow Range Bar Range Contraction
2021-04-16 CPIX Stochastic Reached Oversold Weakness
2021-04-16 GILD Pocket Pivot Bullish Swing Setup
2021-04-16 GILD MACD Bullish Signal Line Cross Bullish
2021-04-16 GILD Golden Cross Bullish
2021-04-16 HEPA Stochastic Buy Signal Bullish
2021-04-16 PLXP Upper Bollinger Band Walk Strength
2021-04-16 PRFX Lower Bollinger Band Walk Weakness
2021-04-16 PRFX New 52 Week Low Weakness
2021-04-16 PRFX New 52 Week Closing Low Bearish
2021-04-16 PRTK Upper Bollinger Band Walk Strength
2021-04-16 PRTK Calm After Storm Range Contraction
2021-04-16 PRTK Cup with Handle Other
2021-04-16 SNY Stochastic Reached Overbought Strength

Recent News for Hepatotoxins Stocks

Date Stock Title
Apr 17 ATXI The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Apr 17 SNY Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe
Apr 16 SNY Vaccinating kids will be very important in getting to herd immunity: Expert
Apr 16 GILD Vaccinating kids will be very important in getting to herd immunity: Doctor
Apr 16 GILD Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline
Apr 16 SNY Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline
Apr 16 SNY Pharma Stock Roundup: JNJ's COVID-19 Vaccine Woes, MRK Ends COVID-19 Drug Development
Apr 15 GILD Gilead Sciences to Release First Quarter 2021 Financial Results on Thursday, April 29, 2021
Apr 15 GILD More domestic medical supply manufacturing is ‘critical’ for the U.S. : Premier President
Apr 15 GILD Biotech Stock Roundup: GILD's UC Drug Approval, REGN's COVID-19 Antibody Data & More
Apr 15 ATXI SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avenue Therapeutics, Inc. - ATXI
Apr 14 GILD Vaccine transparency is ‘the best course of action’: Doctor 
Apr 14 SNY Vaccine transparency is ‘the best course of action’: Doctor 
Apr 14 GILD U.S. in unique position to force increased accountability at the WHO: FDD
Apr 14 SNY U.S. in unique position to force increased accountability at the WHO: FDD
Apr 14 GILD Moderna is committed to keep chasing new COVID variants: CEO
Apr 14 SNY Moderna is committed to keep chasing new COVID variants: CEO
Apr 14 GILD Gilead (GILD) Gets FDA Nod for Trodelvy in Urothelial Cancer
Apr 14 GILD Gilead’s Bladder Cancer Drug Trodelvy Gets FDA Nod
Apr 14 GILD A Peek Into The Markets: US Stock Futures Edge Higher; Bank Earnings In Focus

Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage. Drug-induced liver injury is a cause of acute and chronic liver disease.
The liver plays a central role in transforming and clearing chemicals and is susceptible to the toxicity from these agents. Certain medicinal agents, when taken in overdoses and sometimes even when introduced within therapeutic ranges, may injure the organ. Other chemical agents, such as those used in laboratories and industries, natural chemicals (e.g., microcystins) and herbal remedies can also induce hepatotoxicity. Chemicals that cause liver injury are called hepatotoxins.
More than 900 drugs have been implicated in causing liver injury (see LiverTox, external link, below) and it is the most common reason for a drug to be withdrawn from the market. Hepatotoxicity and drug-induced liver injury also account for a substantial number of compound failures, highlighting the need for toxicity prediction models (e.g. DTI), and drug screening assays, such as stem cell-derived hepatocyte-like cells, that are capable of detecting toxicity early in the drug development process. Chemicals often cause subclinical injury to the liver, which manifests only as abnormal liver enzyme tests.
Drug-induced liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver failures.

More about Hepatotoxins
Browse All Tags